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BACKGROUND: Regionalization of ST-segment elevation myocardial 
infarction (STEMI) systems of care has been championed over the past 
decade. Although timely access to percutaneous coronary intervention 
(PCI) has been shown to improve outcomes, no studies have determined 
how regionalization has affected the care and outcomes of patients. We 
sought to determine if STEMI regionalization is associated with changes in 
access, treatment, and outcomes.
METHODS:  Using a difference-in-differences approach, we analyzed 
a statewide, administrative database of 139 494 patients with STEMI 
in California from 2006 to 2015 using regionalization data based on a 
survey of all local Emergency Medical Services agencies in the state.
RESULTS:  For patients with STEMI, the base rate of admission to 
a hospital with PCI capability was 72.7%, and regionalization was 
associated with an increase of 5.34 percentage points (95% CI, 1.58–
9.10), representing a 7.1% increase. Regionalization was also associated 
with a statistically significant increase of 3.54 (95% CI, 0.61–6.48) 
percentage points in the probability of same-day PCI, representing 
an increase of 7.1% from the 49.7% base rate and a 4.6% relative 
increase (2.97 percentage points [95% CI, 0.1–5.85]) in the probability 
of receiving PCI at any time during the hospitalization. There was a 1.84 
percentage point decrease (95% CI, −3.31 to −0.37) in the probability of 
receiving fibrinolytics. For 7-day mortality, regionalization was associated 
with a 0.53 (95% CI, −1 to −0.06) percentage point greater reduction 
(representing 5.8% off the base rate of 9.1%) and a 1.75 percentage 
point decrease in the likelihood of all-cause 30-day readmission (95% 
CI, −3.39 to −0.11; representing 6.4% off the base rate of 27.4%). No 
differences were found in longer-term mortality.
CONCLUSIONS: Among patients with STEMI in California from 2006 to 
2015, STEMI regionalization was associated with increased access to a 
PCI-capable hospital, greater use of PCI, lower 7-day mortality, and lower 
30-day readmissions.
Association of Cardiac Care Regionalization 
With Access, Treatment, and Mortality Among 
Patients With ST-Segment Elevation Myocardial 
Infarction
ORIGINAL ARTICLE
Shen et al; Effect of STEMI Regionalization on Outcomes
Circ Cardiovasc Qual Outcomes. 2021;14:e007195. DOI: 10.1161/CIRCOUTCOMES.120.007195 March 2021 264
Since 2004, organizations such as the American Heart Association and the American College of Cardiology have endorsed the regionalization of 
cardiac care, particularly for ST-segment elevation myo-
cardial infarction (STEMI).1 Studies have consistently 
shown that patients treated with timely percutaneous 
coronary intervention (PCI) in a high-volume STEMI 
center experience lower morbidity and mortality than 
those treated with fibrinolytic therapy or no interven-
tion.2,3 Due to resource limitations, only 37.1% of all 
acute care, adult hospitals in the United States offer PCI 
lab capability as of 2016.4 Therefore, the goal of these 
regionalization initiatives has been to quickly route or 
transfer patients with suspected STEMI to the nearest 
hospital capable of PCI, bypassing potentially closer 
hospitals without these capabilities.5
STEMI regionalization has been implemented across 
the United States and now covers 67% of the popu-
lation.6,7 Although studies have shown that there has 
been improvement for individuals using process mea-
sures, regionalization efforts have not been shown to 
improve mortality at the population level.8–10 What is 
less definitive is what regionalization has accomplished. 
The existing literature on regionalization is limited by 
single-hospital or single-region studies, the lack of an 
appropriate control group, or minimal accounting for 
secular trends.
This article addresses this gap in the literature by 
determining the extent to which regionalization has 
been associated with changes in overall access to care, 
treatment, and health outcomes for patients with STE-
MI in regionalized versus nonregionalized communi-
ties at the population level, rather than simply at the 
hospital level. Using a difference-in-differences ap-
proach across counties in California that have region-
alized at different time points, we hypothesized that 
cardiac regionalization is associated with significant 
benefits for patients with STEMI through increased 
access to PCI-capable hospitals, greater likelihood of 




Because of the sensitive nature of the data, requests to access 
the dataset may be sent to the California Office of Statewide 
Health Planning and Development.
Data Sources
Several databases were linked to address this population-
based research question. First, nonpublic patient discharge 
and emergency department data from January 1, 2006 to 
September 30, 2015, were obtained from Office of Statewide 
Health Planning and Development. This dataset contains 
every hospitalization and emergency department (ED) 
encounter to nonfederal hospitals in California and includes 
patient demographics, geographic identifier of the patient, 
insurance sources, process and health outcomes, and a rich 
set of comorbidity data identified through International 
Classification of Diseases, Ninth Revision (ICD-9) diagnos-
tic codes. In addition, a unique patient ID was used to track 
whether a patient was readmitted for hospitalization within 
30 days of initial hospital discharge and was linked to vital 
statistics data. We also obtained Vital Statistics data from the 
state of California that were matched to the patient identi-
fiers to track out-of-hospital mortality.
Second, detailed regionalized care arrangement from 
all 33 local Emergency Medical Services (EMS) in California 
was collected through a survey done in 2015.10,11 This data-
set identifies key policy variables in the analysis and contains 
dates of implementation of STEMI regionalization and details 
of these protocols. The governmental structure of EMS in 
California with designated local EMS agencies creates orga-
nized oversight of large urban counties or a collection of mul-
tiple rural counties and allows for the development of such 
EMS-driven systems.
Third, additional hospital organizational characteristics 
(eg, hospital ownership, teaching hospital status, system 
membership, financial characteristics) were captured from the 
American Hospital Association annual hospital surveys, as well 
as annual hospital utilization data from the California Office 
of Statewide Health Planning and Development, which con-
tains annual procedure volumes of several cardiac procedures, 
including PCI. This study was approved by the University of 
California, San Francisco Committee for Human Research.
Patient Selection
Following previous literature, patients with STEMI were 
identified by the ICD-9–Clinical Modification principal 
discharge diagnosis from the emergency department or 
WHAT IS KNOWN
• Regionalization of ST-segment elevation myocar-
dial infarction systems of care has been champi-
oned nationally over the past decade.
• Timely access to percutaneous coronary inter-
vention has been shown to improve outcomes, 
but it is unknown if and how regionalization has 
affected the care and outcomes of patients.
WHAT THE STUDY ADDS
• Among patients with ST-segment elevation myo-
cardial infarction in California from 2006 to 2015, 
ST-segment elevation myocardial infarction region-
alization was associated with increased access to 
a percutaneous coronary intervention-capable 
hospital, greater use of percutaneous coronary 
intervention, lower 7-day mortality, and 30-day 
readmissions.
• Benefits in longer-term mortality were not 
detected.
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inpatient admission was 410.x0 or 410.x1, excluding 
410.7x,7,12 from both the inpatient discharge database as 
well as the emergency department discharge database, 
to capture all patients whether they were admitted to the 
hospital inpatient ward or only to the ED. The patient uni-
verse began with 408 101 cases of acute myocardial infarc-
tion between 2006 and 2015 (excluding 20 518 patients 
who were not California residents). Based on previous 
work,13 71 patients with admissions with length of stay <1 
day (including those who died) were excluded to minimize 
selection bias, as they may have been potential misclassifi-
cations of acute myocardial infarction. Among the remain-
ing 408 303 acute myocardial infarction patients, 139 494 
were identified as STEMI patients. Transfers (both from 
another hospital and from another ED) were also tracked 
so that a patient who was transferred between 2 hospitals 
only appears once in the dataset.
Patient and Public Involvement
This research was done without patient involvement.
Outcomes
The prespecified primary outcomes relevant to the success of 
regionalization included (1) access to a PCI-capable hospital; 
(2) receipt of treatment, defined as separately as receipt of 
same-day PCI or PCI during the hospitalization; and (3) receipt 
of fibrinolytics.
The secondary outcomes included risk-adjusted mortality 
at different time periods (7, 30, 90, and 365 days) and 30-day 
all-cause readmission rates.
The PCI capability of a patient’s admitted hospital was 
identified by linking patient discharge data to the facility data 
via the admitting hospitals’ ID. Therefore, hospitals that began 
to perform PCI during the study period were also incorpo-
rated in the analysis. Given that setting up a PCI lab involves 
a high sunk cost and procedure volume might vary widely or 
be missing in some years, a previously documented smooth-
ing algorithm was used by identifying the opening year of a 
PCI lab in a hospital as the first year of the first consecutive 2 
years in which a hospital reached the PCI volume threshold. 
Closure year was defined as the year after the last year in 
which the hospital met the volume threshold.
The second set of primary outcomes captured proce-
dures received by each patient with STEMI. In particular, 
we used the following ICD-9 procedure codes: PCI (00.66, 
36.00–36.09), both same-day and during the hospitaliza-
tion separately and fibrinolytic therapy (99.10) during the 
hospitalization.14–16 Receipt of fibrinolytics was used as an 
outcome not because this is a goal of regionalization but 
because any increase in early PCI should be accompanied 
by a downward trend of fibrinolytics. Our model included 
coronary angiography (using ICD-9 procedure codes 37.21–
37.23, 88.50–88.57) for patients with STEMI in the defini-
tion of PCI, to capture attempts at intervention. Although 
PCI is generally the definitive treatment for STEMI, inclusion 
of coronary angiography accounts for clinical realities of 
false-positive diagnoses of STEMI, failed PCI attempts, and 
referral to coronary artery bypass grafting in circumstances 
where PCI would be less effective.
As secondary outcomes, mortality of different time peri-
ods was used since studies have found that some system-
level factors (such as access to EDs) have differential effects 
on short-term and long-term mortality rates.17 Examining 
multiple health outcomes provides a more complete pic-
ture in assessing the benefit of such a network (eg, if a 
regionalized scheme only defers death by 1 month by 
precluding immediate death but results in extremely poor 
heart function that leads to later demise, for instance, then 
the cost of operating such a system might outweigh the 
limited benefits). Finally, all-cause 30-day risk-standardized 
readmission rates for patients with STEMI, as defined by 
Centers for Medicare & Medicaid Services (CMS),18 were 
also examined.
Definition of Regionalization
STEMI regionalization networks require complex organization 
and include use of 12 lead EKG and interpretation by EMS, 
designation of STEMI centers with 24/7 PCI availability, com-
mitment to quality improvement, and transfer agreements 
between STEMI referral hospitals and STEMI centers. STEMI 
regionalization does not only entail coordination across EMS 
agencies and hospitals, but also health systems and physician 
groups, as well as continuous feedback and evaluation across 
these providers while ensuring protocol implementation from 
dedicated coordinators. As described in other work,19 an 
objective categorization of STEMI regionalization are rooted 
in 2 class I recommendations specified by the American 
College of Cardiology and American Heart Association, 
where regionalized areas are those that (1) have EMS that 
direct prehospital transport to bypass the nearest hospitals 
that do not offer emergent PCI to facilities that offer emer-
gent PCI for patients with STEMI; and (2) have interhospital 
transfer protocols specifically for patients with STEMI. Using 
this survey10,11 to quantify the degree of regionalization, we 
received a 100% response rate from all local EMS agencies 
covering all 58 counties in California. In the main analysis, a 
county is considered regionalized on and after the year that at 
least 50% of its EMS jurisdiction met either of the 2 criteria. 
Sensitivity analyses further categorized regionalization status 
into partial (if 50%–94% of the EMS jurisdiction met one of 
the criteria but not both), substantial (if 50%–94% of the 
EMS jurisdiction met both criteria), and complete (if at least 
95% of the EMS jurisdiction met both criteria).
Statistical Analysis
A major deficiency in the existing literature is the lack of lon-
gitudinal comparison between regionalized and nonregion-
alized communities. As a result, any benefits in process or 
outcome measures cannot exclude the possibility that these 
are due to secular improvements in care or regional variation 
rather than regionalization network itself.12
To enhance causal identification of the regionalization 
effect, the state of California was used, where counties have 
regionalized in different years. For any adjacent years, some 
counties changed their regionalization status (the treatment 
group) and some did not (ie, the control group). The time 
differences in the implementation across counties allow 
us to implement a difference-in-differences approach that 
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compares changes in outcome between control and treat-
ment groups using county fixed effects. By including county 
fixed effects and year indicators, any unobserved baseline 
differences across counties and secular trend in outcomes 
were removed.
The unit of analysis was the patient. Although all outcomes 
were dichotomous, a linear probability model with county 
fixed effects was employed to identify the STEMI network 
effect on the dependent variable through an indicator that 
takes on the value of 1 on and after the year that a patient’s 
community is switched to a STEMI regionalized network. We 
also included year indicators to control for the macro trends 
of outcomes, county fixed effects controls for unobserved 
time-invariant heterogeneity across counties (including any 
inherent differences in baseline access to technology, and 
case-mix of the underlying population, or other unobserved 
characteristics across communities), patient’s insurance cat-
egories (private, Medicare, Medicaid, indigent care, self-pay, 
and others), patient demographic covariates (eg, 5-year age 
groups, gender, race, and ethnicity), as well as 22 Elixhauser 
patient comorbid indicators to control for underlying individ-
ual patient health conditions.17 Race/ethnicity was recorded 
in the dataset as fixed categories and abstracted from patient 
charts, which could have been from self-determination or 
determined by hospital staff and was measured to account 
for documented disparities in access and receipt of treatment, 
the primary outcomes in this study.
For the variables used in our models, there is a trivial num-
ber of missing data on age (237 cases out of 139 494 obser-
vations, representing 0.17% of the patient population). In 
3915 observations, the PCI capability of the admitted hospital 
(2.8% of the study population) cannot be ascertained. Given 
that PCI capability is the key variable in the model, all mod-
els that contained PCI capability as the independent variable 
were estimated using multiple imputation20 method.
For treatment and health outcomes, a second model 
was implemented to control for the admitting hospital’s PCI 
capacity. Additional sensitivity analyses were implemented to 
provide robustness check and better understanding of the 
mechanisms behind how regionalization might be associated 
with certain outcomes. The first sensitivity model replaced the 
binary regionalization indicator with a more granular data 
on regionalization; the second sensitivity model used a more 
conservative model where the assumption that a catheter-
ization procedure did not equate to PCI, and instead these 
outcomes were analyzed separately; and the third sensitivity 
model stratified analyses based on whether the patient was 
directly admitted to the hospital or was a transfer case. All 
estimations were performed in Stata 16 (Stata Corp, College 
Station, TX), and we used the conventional 5% level of sig-
nificance with 2-sided testing. In addition, we report both the 
unadjusted P value, which assumes the hypothesized rela-
tionship between regionalization and each outcome is inde-
pendent of each other and the adjusted P value for multiple 
comparison using Benjamini-Hochberg method.21
RESULTS
Figure 1 shows the number of patients in regionalized 
and nonregionalized counties over this period. Out of 
139 494 total patients in the study, 77 357 (55.5%) 
were in counties that had regionalized on or before 
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* Number is extrapolated based on data that end in September 30, 2015
Patient distribution by regionalization status
Live in non−regionalized counties
Live in regionalized counties
Figure 1. Patient distribution by regionalization status.
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regionalized to some degree, which we considered 
regionalized. All counties were tracked up to Septem-
ber 30, 2015, for all outcomes except for mortality 
(which are available to us until December 31, 2013; 
therefore, mortality was only calculated for patients 
admitted before December 31, 2012), which ensured 
a sufficient number of postregionalization observa-
tions from all counties.
Table  1 presents patient, hospital, and community 
characteristics of our sample; and further categorize 
the sample into patients living in early adopter (counties 
that were regionalized on and before 2008) and late 
adopter counties. Statistics from Table  1 captured all 
patients with STEMI in California, regardless of whether 
they were treated before or after regionalization; the 
demographic distribution, therefore, reflects that of 
California at large. Counties that implemented region-
alization on or before 2008 had a significantly larger 
population (median population counts is 3 169 776 ver-
sus 1 019 640), higher median family income ($44 474 
versus $36 243), and a higher percentage of Hispanic 
population (21% versus 14% Hispanic patients). Pa-
tients in early adopter counties were more likely to be 
admitted to larger (median hospital bed size 316 versus 
264) and public hospitals (17% versus 11% govern-
ment-run hospitals). Approximately 14% of patients 
were transferred to another hospital in early adopter 
counties, with 67% of those transfers receiving PCI at 
the second hospital; in late adopter counties, 19% of 
patients were transferred, with 71% of those patients 
receiving PCI at the second hospital.
Figures 2 and 3 show the trends of selected unad-
justed outcomes. Although our empirical model cap-
tures the exact year a given county became regional-
ized, for clarity of presentation, we show the trends 
separately for counties that were regionalized on or 
before 2008 and those that were regionalized after 
2008. The early adopters had a statistically higher 
percentage of patients being admitted to PCI hospital 
in 2006 than the late adopters (75% versus 66% in 
2006), but by the end of the study period in 2014, 
the late adopters did not have a statistically differ-
ent level (86%) of PCI access. The increasing prob-
ability of receiving PCI procedure during this period 
also did not differ significantly between patients in 
early and late adopter counties (from 66% in 2006 to 
84% in 2015 in early adopters and from 62% to 86% 
in late adopter counties). Both early and late adopt-
ers showed a decreasing trend in patients receiving 
fibrinolytic therapy, with a larger decline in patients 
from late adopter counties. Mortality and readmission 
rates also improved for all counties during this period. 
Our empirical analysis takes into account these macro 
trends that are common across all counties.
Table  2 shows that 72.7% of patients were ad-
mitted to a PCI-capable hospital at baseline in 2006. 
Regionalization was associated with a 5.34 percentage 
point increase (95% CI, 1.58–9.10) in the likelihood of 
being admitted to a hospital with PCI capability for pa-
tients whose counties became regionalized compared 
with patients in counties that did not have a change 
in regionalization status, reflecting a 7.1% increase in 
access associated with regionalization (full regression 
results in Table I in the Data Supplement).
The top panel of Table 2 also shows the net effect 
of regionalization on treatment outcomes, in that 
we did not control for PCI capacity at site of care. At 
baseline, 49.7% of patients with STEMI received a PCI 
procedure on the same day of hospitalization. Region-
alization was associated with a statistically significant 
increase of 3.54 percentage points in the probability 
of receiving same-day PCI (95% CI, 0.61–6.48), repre-
senting a 7.1% increase in PCI treatment. In addition, 
we found regionalization was associated with a growth 
of 2.97 percentage points in the probability of receiv-
ing PCI during the hospitalization (95% CI, 0.1–5.85; 
equivalent to a 4.6% increase given that 64.2% of pa-
tients with STEMI received PCI during the hospitaliza-
tion). Regionalization was also associated with a 1.84 
percentage point decrease (95% CI, −3.31 to −0.37) 
in the probability of receiving fibrinolytics for patients 
with STEMI, reflecting a 24.9% relative decrease off the 
baseline of 7.4%.
The top panel of Table 3 shows the net association of 
regionalization on health outcomes (full regression re-
sults in Table I in the Data Supplement). We did not find 
any statistically significant association with 30-day, 90-
day, or 1-year mortality, although we did find a small 
0.53 percentage point reduction (95% CI, −1 to −0.06) 
in 7-day mortality (equivalent to 5.8% reduction off 
the baseline of 9.1%) and a 1.75 percentage point de-
crease in the likelihood of all-cause 30-day readmission 
(95% CI, −3.39 to −0.11), equivalent to 6.4% reduc-
tion off the baseline 27.4% readmission rate.
The bottom panels of Tables 2 and 3 show that con-
ditional on being admitted to a PCI-capable hospital, 
aside from a statistically significant decrease in the 
likelihood of receiving fibrinolytic therapy, there were 
no statistically significant differences in treatment and 
health outcomes between patients in regionalized and 
nonregionalized counties. These results suggest that 
the benefit of regionalization observed in Table 2 was 
largely through the improved access to PCI-capable 
hospitals, but that regionalization also did—separately 
from access to PCI centers—change the practice of ad-
ministering fibrinolytic therapy to patients with STEMI.
For our sensitivity analyses, the association of re-
gionalization on these outcomes did not differ when 
analyzing outcomes by more granular categories of re-
gionalization (Table II in the Data Supplement)—there 
were no statistically significant differences in the es-
timated change in all outcomes across counties that 
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Table 1. Patient, Hospital, and Community Characteristics by STEMI Regionalization Status
 
All patients be-
tween 2006 and 
2015
Patients in counties 
that were regional-
ized on or before 
2008
Patients in counties 
that were regional-
ized after 2008
No. of patients 139 494 (100%) 77 357 (100%) 62 137 (100%)
Gender
 Male 93 694 (67%) 52 202 (67%) 41 492 (67%)
 Female 45 800 (33%) 25 155 (33%) 20 645 (33%)
Race/ethnicity
 White (non-Hispanic) 86 392 (62%) 44 276 (57%) 42 116 (68%)
 Hispanic 24 778 (18%) 16 143 (21%) 8635 (14%)
 Asian 12 620 (9%) 7423 (10%) 5197 (8%)
 Other/mixed 7900 (6%) 4551 (6%) 3349 (5%)
 Black (non-Hispanic) 7804 (6%) 4964 (6%) 2840 (5%)
Age, y
 <40 3304 (2%) 1869 (2%) 1435 (2%)
 40–54 28 568 (21%) 15 725 (20%) 12 843 (21%)
 55–64 35 391 (25%) 19 524 (25%) 15 867 (26%)
 65–69 16 419 (12%) 9014 (12%) 7405 (12%)
 70–74 13 831 (10%) 7556 (10%) 6275 (10%)
 75–79 12 862 (9%) 7207 (9%) 5655 (9%)
 80–84 12 423 (9%) 6939 (9%) 5484 (9%)
 85–99 16 459 (12%) 9369 (12%) 7090 (11%)
Insurance (expected source of payment)
 Private 44 058 (32%) 24 547 (32%) 19 511 (31%)
 Medicare 67 898 (49%) 37 115 (48%) 30 783 (50%)
 Medicaid 13 230 (9%) 7829 (10%) 5401 (9%)
 Indigent (county or other) 3913 (3%) 2364 (3%) 1549 (2%)
 Patient 7243 (5%) 3909 (5%) 3334 (5%)
 Other 3152 (2%) 1593 (2%) 1559 (3%)
Transfer status
 Transferred to another hospital 23 096 (17%) 10 989 (14%) 12 107 (19%)
  Received PCI treatment after transfer 15 968 (69%) 7366 (67%) 8602 (71%)
Admitting hospital characteristics
 Ownership
  For-profit 20 787 (15%) 11 375 (15%) 9412 (15%)
  Government 17 386 (14%) 11 511 (17%) 5875 (11%)
 Teaching hospital* 13 941 (11%) 8035 (12%) 5906 (11%)
 Hospital is part of a system 88 624 (75%) 46 854 (72%) 41 770 (78%)
 Median number of beds (IQR) 293 (163) 316 (174) 264 (161)
 Mean occupancy rate (SD)† 0.66 (0.14) 0.67 (0.14) 0.66 (0.14)
 Median HHI within 15 miles based on total discharge (IQR)‡ 0.14 (0.23) 0.08 (0.18) 0.19 (0.26)
 CABG availability 103 655 (76%) 59 491 (78%) 44 164 (74%)
 PCI lab availability§ 113 810 (84%) 64 039 (85%) 49 771 (83%)
Community characteristics
 Median county population (IQR) 2 017 673 (2 519 404) 3 169 776 (8 359 181) 1 019 640 (1 592 743)
 Median per capita income (IQR) 42 265 (15 326) 44 474 (8533) 36 243 (19 785)
(Continued )
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were classified as partially, substantially, and completely 
regionalized categories. The second sensitivity analysis 
(Table III in the Data Supplement) shows the results of 
using a narrower definition of PCI as an outcome that 
excludes catheterization, with similar results. Finally, Ta-
ble IV in the Data Supplement provides stratified results 
by direct admit patients with STEMI and those patients 
with STEMI who were transferred, showing a larger 
benefit in all primary outcomes and several secondary 
outcomes for direct admit patients. However, this table 
should be interpreted with caution, as regionalization 
itself could change the composition and the underlying 
mortality risk of transfer patients because interhospital 
transfer protocols may facilitate transport of sicker pa-
tients who would have stayed at the non-PCI hospital 
previously.
DISCUSSION
Regionalization in California was associated with an 
improvement in access to PCI-capable hospitals and 
subsequent receipt of PCI. Regionalization was also as-
sociated was a statistically significant reduction in 30-
day readmissions and 7-day mortality, with admittedly 
larger confidence intervals. This 7-day mortality benefit 
did not translate into longer-term mortality reductions.
These findings importantly contribute to our under-
standing of the effects of regionalization. Although re-
gionalization has been shown to improve door-to-bal-
loon times (DTB) and first medical contact to device,8 
and these process measures have been associated with 
decreased mortality,22 the relationship between region-
alization and improved mortality in the United States 
has been less definitive.23 Few studies of multiple re-
gions to date that have used a control group. One study 
with Medicare patients in North Carolina showed that 
improvements in mortality were the same as seen in 
nonintervention groups and were likely due to secular 
improvements in STEMI mortality.7 Another important 
study evaluating the addition of regional coordinators 
to existing STEMI regionalization efforts used a control 
group of hospitals already participating in a registry 
and showed a mortality benefit; however, because only 
selected hospitals participated, the population-based 
effects of regionalization (to account for patients who 
did not present to participating hospitals) could not be 
ascertained.24 Other studies examining mortality before 
and after regionalization have been unable to show any 
effect.8–10
Like other studies,24,25 the improved short-term mor-
tality associated with regionalization in California in this 
study did not persist over the longer-term. If regional-
ization has been shown to decrease DTB times,8,26 and 
decreased DTB times are associated with improvements 
in mortality, why have studies of regionalization been 
unable to be directly show improvements in longer-term 
mortality? There are several possibilities. First, patients 
may actually take a longer time to reach the door (the 
PCI-equipped hospital). Using DTB or similar process 
measures, therefore, ignore the consideration of longer 
field or transit times. The conflicting evidence22,27 and 
apparent dissociation between DTB times and mortality 
has been recognized by others23 who have noted that 
DTB times are only one component of many different 
factors associated with STEMI mortality and, therefore, 
may not provide an accurate measure of regionaliza-
tion outcomes. This is now recognized as the field has 
moved towards measuring first medical contact to de-
vice times. In addition, regionalization efforts to push 
interhospital transfer could potentially have an unin-
tended consequence of increasing symptom to reperfu-
sion times if fibrinolytics could have been administered 
significantly earlier.
Second, although treatment with PCI has been 
shown to lower mortality rates,2 and regionalization 
may improve access to PCI, effects from regionalization 
may be difficult to find because even without formal 
or governmental regionalization schemes, there can 
be de facto regionalization where hospitals may create 
transfer relationships with PCI centers for patients with 
STEMI even when not under a regionalization scheme. 
In addition, it is possible that the growth of PCI centers 
  Live in low-income ZIP code communities (lowest quartile 
of family income distribution)
33 102 (24%) 7590 (10%) 25 512 (41%)
 Live in counties with high share of Black population 42 354 (30%) 22 257 (29%) 20 097 (32%)
 Live in counties with high share of Hispanic population 39 205 (28%) 27 820 (36%) 11 385 (18%)
CABG, indicates coronary artery bypass grafting; HHI, Herfindahl-Hirschman Index; IQR, interquartile range; PCI, percutaneous coronary 
intervention; and STEMI, ST-segment elevation myocardial infarction.
*If residents-to-bed ratio>0.25.
†Total inpatient days/available beds.
‡HHI is a measure of hospital market’s competitiveness and ranges from 0 (perfectly competitive) to 1 (monopoly).
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in hospitals across the United States may have reached 
a point that there is not sufficient volume to sustain 
operator expertise.28 Already in 2010, <12% (574 of 
4931) of all hospitals offered PCI for a high volume of 
patients with STEMI (>40 primary PCI annually), with 
even fewer of these supporting round-the-clock avail-
ability.29 Another study showed that despite a decreas-
ing prevalence of myocardial infarction, PCI centers 
have increased at a rate 1.5x that of the population,30 
potentially exacerbating a situation of oversupply of PCI 
hospitals. The volume-outcomes relationship is well-
documented across numerous conditions, including 
cardiac care, such that mortality rates can differ by 28% 
when comparing the highest-volume angioplasty hos-
pitals with the lowest-volume angioplasty hospitals.3,31
Third, it is possible that regionalization has had 
an unintended consequence of creating a one-way 
valve, where any cardiac patient may be more likely 
re-directed to PCI hospitals, and large percentages of 
inappropriately diverted patients could overwhelm ex-
isting resources.32 Similarly, bypassed hospitals that do 
not offer PCI experience may see fewer patients with 
myocardial infarction, which may decrease their expe-
rience and impede their ability to provide high-quality 
care. There could also be financial consequences of 
lower volumes of cardiac patients for these hospitals, 
with the downstream threat of overall decreased ac-
cess to the healthcare system if these facilities become 
financially unsustainable. Finally, most studies are not 
sufficiently powered enough to detect a small change 
in an outcome such as longer-term mortality, which 
can be overwhelmed by noise from variation in other 
causes of death.
Given that regionalization is typically implemented 
in an effort to better treat the entire community, pop-
ulation-based studies are needed to assess the effects 
of regionalization on access, treatment, and outcomes 
for all patients with the target condition, not only those 
who actually receive certain treatments. The findings 
of this study raise questions regarding the larger con-
text in which hospitals provide services such as PCI. 
Although others have also modeled cost-effectiveness 
of regionalization strategies to include quality-adjusted 
life-years, and shown that EMS-based strategies are 
less costly and more effective than any type of hospi-
tal expansion option,26,33 economic incentives are such 
that PCI expansion may continue, despite decreasing 
prevalence of STEMI.12 At best, this study shows that re-
gionalization efforts may shift the timing of death from 
7 days to only slightly later. Therefore, although region-
alization has improved access, the effect on health out-
































































Process trends among all STEMI patients by regionalization period
regionalized on or before 2008 regionalized after 2008
Figure 2. Process trends among all patients with ST-segment elevation myocardial infarction (STEMI) by regionalization period.
PCI indicates percutaneous coronary intervention.
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A final important finding of this study lies in the fact 
that even though all counties were regionalized as of 
2012, not all patients with STEMI were sent to PCI-ca-
pable hospitals (<90% even as of 2015). And although 
we found that regionalization networks were statistically 
associated with a greater likelihood of receiving PCI, the 
percentage of patients with STEMI receiving PCI was still 
well below 80% at the end of the study period. Although 
certainly there are clinical contraindications for PCI, these 
findings may support other literature documenting a sys-
tematic duplication of PCI centers in communities that 
already have access, are wealthier, and have more private 
insurance, whereas significant gaps in access remain for 
other underserved communities.4,34 Concannon et al35 
have shown that in a short 5-year period, PCI-capable 
hospitals proliferated by 44% but only improved popula-
tion access to PCI by 1%. These larger environmental fac-
tors may prove challenging in efforts to regionalize care 
in high-volume centers, with implications not only for 
the regionalization of cardiac care but also other condi-
tions, such as stroke and trauma,36,37 where hospitals may 
experience differential financial effects from service-line 
specialization.
Limitations
This study has several limitations. First, we used ad-
ministrative data using discharge diagnoses, and 
STEMI coding was changed in 2005, introducing a po-
tential concern regarding consistent capture of STEMI 
admissions with ICD-9 coding. However, validity test-
ing of these codes has been done in previous literature 
with other administrative data, with the finding that 
trends in STEMI over time have been consistent; Yeh 
et al,12 for example, found that STEMI coding from 
1999 to 2008 has been fairly consistent and accurate 
over time when compared with detailed chart review 
of a Kaiser health system, even despite the change in 
ICD-9 coding in 2005. We chose to be conservative 
and included only the postrevision time period from 
2006 to 2012. Nevertheless, the positive predictive 
value found in other data sets using these ICD-9 codes 
could differ in our state administrative data. We did 
investigate the potential of using registries with more 
physician-based diagnoses, such as the American Col-
lege of Cardiology/American Heart Association’s Acute 
Coronary Treatment and Intervention Outcomes Net-
work (ACTION) Registry-Get With The Guidelines and 
Cardiac Catheterization and Percutaneous Coronary 
Intervention (CathPCI) Registry. However, the former 
are unable to provide historical information due to 
merging of several modules after 2008, and most AC-
TION participants are STEMI receiving hospitals. The 
marked absence of STEMI referral hospitals renders it 
impossible to determine differences among communi-























































Outcome trends among all STEMI patients by regionalization period
regionalized on or before 2008 regionalized after 2008
Figure 3. Outcome trends among all patients with ST-segment–elevation myocardial infarction (STEMI) by regionalization period.
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mortality. The CathPCI Registry captures only patients 
who received PCI and, therefore, precludes evaluation 
of all patients with STEMI in an integrated STEMI sys-
tem. Neither allows outcomes evaluation at the popu-
lation level. In fact, the percentage of STEMI patients 
receiving PCI in our population-based study, which 
includes all hospitals, including the small, non-PCI–
capable hospitals, may be lower than the majority of 
published studies that rely on registry data to provide 
estimates of STEMI treatment for PCI patients because 
these registries include only hospitals who choose 
to participate in these cardiac quality improvement 
efforts. Because our data, however, do not include 
granular clinical data, such as number of minutes from 
first medical contact to intervention, we were unable 
to calculate improvements in such measurements.
Second, our study accounted for both inpatient pa-
tients and those who were only admitted through the 
emergency department but did not account for a cer-
tain proportion of deaths that may occur in the field, 
during transport, or in the ED. However, given the dif-
ficulty of diagnosing cause of death and the relatively 
rare nature of this event, we do not expect this to sig-
nificantly affect our results.




7-d mortality 30-d mortality 90-d mortality 1-y mortality 30-d readmission
No. of patients 117 896 117 896 117 896 117 896 139 257
Sample mean at baseline, % 9.1% 13.6% 16.6% 21.4% 27.4%
Unadjusted for site of care PCI capacity
  Percentage point change on and after county 
is regionalized
−0.53 −0.46 −0.38 −0.32 −1.75
  95% CI [−1.00 to −0.06] [−1.12 to 0.20] [−1.05 to 0.28] [−0.87 to 0.23] [−3.39 to −0.11]
  Unadjusted P value 0.027 0.170 0.250 0.250 0.037
  Adjusted P value for multiple comparison 0.045 0.212 0.250 0.250 0.053
Adjusted for site of care PCI capacity
  Percentage point change on and after county 
is regionalized
−0.37 −0.24 −0.15 −0.03 −0.70
  95% CI [−0.90 to 0.16] [−0.98 to 0.49] [−0.87 to 0.58] [−0.58 to 0.51] [−2.01 to 0.62]
  Unadjusted P value 0.167 0.508 0.684 0.908 0.292
  Adjusted P value for multiple comparison 0.835 0.908 0.908 0.908 0.908
Full regression controls for patient demographics, insurance category, comorbid conditions, county fixed effects, and year dummies are presented in Table I in the 
Data Supplement. PCI indicates percutaneous coronary intervention.
Table 2. Changes in Process Outcomes Between Counties That Changed Regionalization Status and Counties That Did Not During the Same Period
Primary outcomes (process)
Admitted to PCI 
hospital
Received PCI on the 
same day




No. of patients 135 579 139 257 139 257 139 257
Sample mean at baseline (%) 72.7% 49.7% 64.2% 7.4%
Unadjusted for site of care PCI capacity
  Percentage point change on and after county is 
regionalized
5.34 3.54 2.97 −1.84
  95% CI [1.58 to 9.10] [0.61 to 6.48] [0.10 to 5.85] [−3.31 to −0.37]
  Unadjusted P value 0.006 0.019 0.043 0.015
  Adjusted P value for multiple comparison 0.024 0.038 0.043 0.038
Adjusted for site of care PCI capacity
  Percentage point change on and after county is 
regionalized
NA −0.35 0.56 −1.47
  95% CI NA [−2.17 to 1.46] [−1.40 to 2.53] [−2.70 to −0.23]
  Unadjusted P value NA 0.699 0.568 0.021
  Adjusted P value for multiple comparison NA 0.699 0.699 0.063
Full regression controls for patient demographics, insurance category, prior acute myocardial infarction admission, comorbid conditions, county fixed effects, and 
year dummies are presented in Table I in the Data Supplement. NA indicates not applicable; and PCI, percutaneous coronary intervention.
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Third, it is possible we did not have enough post 
regionalization observations for mortality outcomes 
from all counties, especially those that regionalized af-
ter 2012, so that we did not detect a mortality effect. 
Fourth, although our approach removes any time-in-
variant unobserved differences between the 2 groups, 
there may still be concerns that our results were driven 
by significant differences between regionalized and 
nonregionalized communities that could be account-
ed for in our study. To address the concern that there 
might be intrinsic time-varying differences between re-
gionalized and nonregionalized counties that cannot 
be removed via the difference-in-differences method, 
2 additional analyses were implemented. First, Figure 
I in the Data Supplement shows that mortality trends 
during the preregionalization period (2001–2005) were 
similar across counties that were early and late adopt-
ers of regionalization network, with parallel mortality 
trends between both types of counties in the prere-
gionalization period. Second, we implemented a sen-
sitivity analysis where we matched patients based on 
the pretrend (ie, slope) of the community’s mortality 
trend during the pretreatment period. This is essentially 
a propensity score matching based on pretrend slope, 
excluding patients outside of the common support re-
gion. Table IV in the Data Supplement shows similar re-
sults as our main table (with slightly larger magnitude).
Conclusions
Among patients with STEMI in California from 2006 
to 2015, STEMI regionalization was associated with in-
creased access to a PCI-capable hospital, greater use 
of PCI, and lower 7-day mortality but no difference in 
longer-term mortality.
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